Precise mapping reveals gaps in global measles vaccination coverage

C. Edson Utazi,Andrew J. Tatem
DOI: https://doi.org/10.1038/d41586-020-03391-1
IF: 64.8
2020-12-16
Nature
Abstract:Improved access to childhood vaccines has been one of the biggest breakthroughs in public health in recent decades, as evidenced by the eradication of smallpox in 1980 and this year's declaration of Africa as polio-free<sup><a href="#ref-CR1">1</a></sup>. But for measles, the road towards elimination and eradication has been bumpy, despite the existence of a safe and cost-effective vaccine. Measles cases and deaths persist, particularly in low- and middle-income countries (LMICs; see <a href="http://go.nature.com/37raIbw">go.nature.com/37raIbw</a>), where many factors — from conflict to vaccine hesitancy and underfunding — continue to pose challenges to immunization. <a href="https://www.nature.com/articles/s41586-020-03043-4">Writing in <i>Nature</i></a><sup><a href="#ref-CR2">2</a></sup>, a group called the Local Burden of Disease Vaccine Coverage Collaborators provides evidence that targets for measles vaccination are in jeopardy, owing to major inequities in coverage, together with the slowdown, stagnation and regression of the coverage of routine first-dose measles vaccines between 2010 and 2019.
multidisciplinary sciences
What problem does this paper attempt to address?